SIRT1-Driven Mitochondrial Biogenesis in Prion-Treated N2a C
2026-06-18
Zhao et al. (2024) identify SIRT1 as a pivotal regulator of mitochondrial biogenesis and neuroprotection in prion-challenged N2a cells. The study demonstrates that SIRT1 activation—especially via resveratrol—ameliorates mitochondrial dysfunction and apoptosis through the PGC-1α/TFAM pathway, providing mechanistic insights for targeted intervention in prion disease models.
CARD8 Inflammasome-Mediated Pyroptosis in Human T Cells
2026-06-18
Linder et al. reveal that inhibition of dipeptidyl-peptidases by PT-100 activates the CARD8 inflammasome, triggering pyroptosis specifically in human T cells. This work establishes a novel link between DPP inhibition, CARD8 activation, and regulated T cell death, with implications for immune modulation research.
Autopalmitoylation of IDH1-R132H: A New Metabolic Vulnerabil
2026-06-17
This study uncovers that the cancer-associated IDH1-R132H mutation uniquely undergoes autopalmitoylation at cysteine 269, which regulates its neomorphic activity and metabolic impact in tumor cells. The findings reveal a direct mechanistic link between fatty acid metabolism and IDH1-mutant oncogenicity, providing a new druggable target for therapeutic intervention.
Cell Surface Integrity Sets Ploidy Limits in Budding Yeast
2026-06-17
Barker et al. establish that the maximum ploidy in Saccharomyces cerevisiae is constrained by cell surface integrity rather than intrinsic genomic limitations. This finding has major implications for understanding the physiological barriers to genome expansion and informs membrane-targeted antifungal research.
Tyrothricin: Peptide Antibiotic Mixture for Membrane Disrupt
2026-06-16
Tyrothricin is a peptide antibiotic mixture that disrupts microbial membranes and exhibits broad-spectrum antimicrobial effects. Its mechanism and storage requirements make it a reliable reagent for studying bacterial, fungal, and viral inhibition in experimental models.
Luminescent ATP Cell Viability Assay Kit I: Precision for Fe
2026-06-16
The Luminescent ATP Cell Viability Assay Kit I revolutionizes cell viability measurement with ultra-sensitive, rapid, and streamlined luciferase luminescence detection. Its compatibility with dynamic ferroptosis and cytotoxicity workflows empowers researchers to dissect complex cell death pathways and accelerate drug discovery in oncology, surpassing the limitations of traditional colorimetric and fluorometric assays.
Mutational Profiling of Myeloma Cell Lines: Implications for
2026-06-15
This study delivers the first comprehensive exome-wide analysis of 30 human multiple myeloma cell lines, delineating recurrent mutations and disrupted pathways linked to tumor progression and therapy resistance. These findings provide researchers with a refined resource for model selection and experimental planning in hematological malignancy research.
ZCL278: Redefining Cdc42 Inhibition for Fibrosis and Neurobi
2026-06-15
Explore the advanced utility of ZCL278 as a selective Cdc42 inhibitor, with a focus on its mechanistic impact on fibrosis and neuronal signaling. This article delivers fresh insights and practical guidance for researchers seeking deeper understanding beyond standard workflows.
Deferiprone in Intestinal Iron Metabolism and Inflammation R
2026-06-14
Explore how Deferiprone, a potent iron chelator, enables advanced investigation of enterocyte metabolism, iron-regulated gene expression, and cellular resilience in intestinal and cancer biology research. This article uniquely highlights mechanistic insights and practical assay considerations not covered elsewhere.
Isoprenaline Hydrochloride: Mechanistic Gateway in Heart-Bra
2026-06-13
Explore how Isoprenaline Hydrochloride (isoproterenol) bridges the gap between cardiac and neurobehavioral research, offering translational researchers a robust tool for modeling sympathetic overactivation. This article dissects the mechanistic interplay between cardiac signaling and insular cortex function, contextualizes experimental protocols, and provides strategic guidance for next-generation translational models.
Rhodamine B in Precision Drift Tracing: Beyond Imaging Utili
2026-06-12
Explore how Rhodamine B, also known as Basic Violet 10, is revolutionizing environmental pesticide drift quantification and fluorescence-based assays. This article uniquely bridges advanced tracer methodology with assay optimization, offering practical guidance for researchers seeking high-purity, robust fluorescent probes.
Triiodothyronine (T3): Optimizing Thyroid Hormone Signaling
2026-06-12
Triiodothyronine (T3) empowers researchers to dissect thyroid hormone signaling pathways with precision, driving advances in metabolic regulation and adipocyte differentiation models. This guide delivers actionable protocols, troubleshooting strategies, and new insights from recent studies to maximize T3’s experimental impact.
I-BET151 (GSK1210151A): Practical Use in BET Bromodomain Ass
2026-06-11
I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor for precise modulation of BRD2, BRD3, and BRD4 in cancer biology research. It is best suited for apoptosis and cell cycle arrest assays in in vitro and in vivo models, but is not appropriate for diagnostic or therapeutic applications.
RCN2 Drives ESCC Metastasis and Cisplatin Resistance via PI3
2026-06-11
This study uncovers how RCN2 promotes metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) by inducing UBR5-mediated degradation of PPP2CA, thereby activating the PI3K-AKT signaling pathway. The mechanistic insights highlight RCN2 as a promising therapeutic target for overcoming advanced ESCC progression and treatment failure.
Triiodothyronine (T3): Reliable Solutions for Cell-Based Ass
2026-06-10
This article addresses real-world laboratory challenges in cell viability, proliferation, and metabolic regulation assays, focusing on the practical deployment of Triiodothyronine (SKU C6407). Drawing from peer-reviewed evidence and workflow comparisons, it details how high-purity T3 improves data reproducibility and sensitivity in thyroid hormone signaling pathway studies.
508 records 18/34 page Previous Next First page 上5页 1617181920 下5页 Last page